Ciro Celsa

2.5k total citations
59 papers, 771 citations indexed

About

Ciro Celsa is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Ciro Celsa has authored 59 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 31 papers in Epidemiology and 21 papers in Oncology. Recurrent topics in Ciro Celsa's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers) and Hepatitis C virus research (10 papers). Ciro Celsa is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers) and Hepatitis C virus research (10 papers). Ciro Celsa collaborates with scholars based in Italy, United Kingdom and Spain. Ciro Celsa's co-authors include Calogero Cammà, Salvatore Petta, Grazia Pennisi, Federica Spatola, Giuseppe Cabibbo, Matteo Tacelli, Marco Enea, Bianca Magro, Antonio Craxı̀ and V. Di Marco and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Gut.

In The Last Decade

Ciro Celsa

53 papers receiving 762 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ciro Celsa 427 334 223 211 141 59 771
Daichi Takizawa 270 0.6× 408 1.2× 128 0.6× 204 1.0× 159 1.1× 57 821
Yeonjung Ha 472 1.1× 518 1.6× 177 0.8× 105 0.5× 74 0.5× 50 848
Kenichiro Seki 307 0.7× 132 0.4× 187 0.8× 145 0.7× 76 0.5× 37 732
Michitaka Matsuda 340 0.8× 211 0.6× 201 0.9× 299 1.4× 161 1.1× 33 894
Edward Mena 471 1.1× 364 1.1× 79 0.4× 123 0.6× 47 0.3× 28 696
Yasuaki Takeyama 268 0.6× 219 0.7× 203 0.9× 201 1.0× 48 0.3× 67 617
Jianhua Wang 181 0.4× 222 0.7× 176 0.8× 149 0.7× 86 0.6× 42 589
R Vecchione 518 1.2× 364 1.1× 103 0.5× 197 0.9× 64 0.5× 35 928
P J Winwood 396 0.9× 494 1.5× 112 0.5× 189 0.9× 56 0.4× 13 833
Roongruedee Chaiteerakij 289 0.7× 220 0.7× 323 1.4× 508 2.4× 275 2.0× 40 943

Countries citing papers authored by Ciro Celsa

Since Specialization
Citations

This map shows the geographic impact of Ciro Celsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciro Celsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciro Celsa more than expected).

Fields of papers citing papers by Ciro Celsa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciro Celsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciro Celsa. The network helps show where Ciro Celsa may publish in the future.

Co-authorship network of co-authors of Ciro Celsa

This figure shows the co-authorship network connecting the top 25 collaborators of Ciro Celsa. A scholar is included among the top collaborators of Ciro Celsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciro Celsa. Ciro Celsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fulgenzi, Claudia Angela Maria, Alessia Dalla Pria, Alberto Giovanni Leone, et al.. (2025). Hepatocellular carcinoma in people living with HIV. Journal of Hepatology. 83(4). 971–981.
3.
Pennisi, Grazia, Marco Enea, Ciro Celsa, et al.. (2025). A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta‐Analysis. Liver International. 45(4). e70056–e70056. 1 indexed citations
4.
5.
Celsa, Ciro, Pasquale Lombardi, Antonio D’Alessio, et al.. (2025). Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma. JAMA Oncology. 11(10). 1160–1160.
6.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2024). Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. Clinical Cancer Research. 31(3). 543–550. 6 indexed citations
8.
Martin, Eléonora De, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.. (2024). Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events. Gut. 74(7). 1165–1177. 13 indexed citations
9.
D’Alessio, Antonio, Bernardo Stefanini, Claudia Angela Maria Fulgenzi, et al.. (2024). Qualification of major pathological response as a surrogate endpoint for relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.. Journal of Clinical Oncology. 42(3_suppl). 506–506. 2 indexed citations
10.
Pennisi, Grazia, Ciro Celsa, Marco Enea, et al.. (2024). Clinical outcomes of MAFLD versus NAFLD: A meta‐analysis of observational studies. Liver International. 44(11). 2939–2949. 12 indexed citations
11.
Celsa, Ciro, Giacomo Emanuele Maria Rizzo, Marco Enea, et al.. (2024). What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis. Liver International. 44(11). 2890–2903. 1 indexed citations
12.
Maida, Marcello, Ciro Celsa, Louis Ho Shing Lau, et al.. (2024). The Application of Large Language Models in Gastroenterology: A Review of the Literature. Cancers. 16(19). 3328–3328. 3 indexed citations
13.
Pennisi, Grazia, Ciro Celsa, Marco Enea, et al.. (2022). Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 32(10). 2279–2288. 17 indexed citations
14.
Celsa, Ciro, Federica Spatola, Giacomo Emanuele Maria Rizzo, et al.. (2021). Systemic therapies for hepatocellular carcinoma: the present and the future. Recenti Progressi in Medicina. 112(2). 110–116. 4 indexed citations
15.
Cabibbo, Giuseppe, María Reig, Ciro Celsa, et al.. (2021). First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials. Liver Cancer. 11(1). 75–84. 25 indexed citations
16.
Tacelli, Matteo, Ciro Celsa, Bianca Magro, et al.. (2020). Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐analysis. Digestive Endoscopy. 32(7). 1018–1030. 57 indexed citations
17.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2020). Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis. Cancers. 12(8). 2132–2132. 16 indexed citations
18.
Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2020). Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma. Cancers. 13(1). 90–90. 20 indexed citations
19.
Pennisi, Grazia, Ciro Celsa, Federica Spatola, et al.. (2019). Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. International Journal of Environmental Research and Public Health. 16(22). 4334–4334. 23 indexed citations
20.
Cabibbo, Giuseppe, M. Rossi, Ciro Celsa, Marcello Maida, & Calogero Cammà. (2018). Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?. Recenti Progressi in Medicina. 109(12). 605–608. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026